Literature DB >> 7236492

A marker for hypoxic cells in tumours with potential clinical applicability.

J D Chapman, A J Franko, J Sharplin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7236492      PMCID： PMC2010627          DOI： 10.1038/bjc.1981.79

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

Authors:  L H GRAY; A D CONGER; M EBERT; S HORNSEY; O C SCOTT
Journal:  Br J Radiol       Date:  1953-12       Impact factor: 3.039

Review 2.  Chemical radiosensitization of hypoxic cells.

Authors:  G E Adams
Journal:  Br Med Bull       Date:  1973-01       Impact factor: 4.291

3.  Nitrofurans as radiosensitizers of hypoxic mammalian cells.

Authors:  J D Chapman; A P Reuvers; J Borsa; A Petkau; D R McCalla
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

4.  Radiotherapy and hyperbaric oxygen in head and neck cancer. Interim report of second clinical trial.

Authors:  J M Henk; C W Smith
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

5.  Radiation and high-dose metronidazole in supratentorial glioblastomas.

Authors:  R Urtasun; P Band; J D Chapman; M L Feldstein; B Mielke; C Fryer
Journal:  N Engl J Med       Date:  1976-06-17       Impact factor: 91.245

6.  Definitive evidence for hypoxic cells influencing cure in cancer therapy.

Authors:  R S Bush; R D Jenkin; W E Allt; F A Beale; H Bean; A J Dembo; J F Pringle
Journal:  Br J Cancer Suppl       Date:  1978-06

7.  Mode of action of nitrofurazone.

Authors:  D R McCalla; A Reuvers; C Kaiser
Journal:  J Bacteriol       Date:  1970-12       Impact factor: 3.490
  7 in total
  65 in total

1.  Early wound healing exhibits cytokine surge without evidence of hypoxia.

Authors:  Z A Haroon; J A Raleigh; C S Greenberg; M W Dewhirst
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 2.  Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.

Authors:  Peter Wardman
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

Review 3.  Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation.

Authors:  C L McCoy; D J McIntyre; S P Robinson; E O Aboagye; J R Griffiths
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 4.  Kinetic modeling in PET imaging of hypoxia.

Authors:  Fan Li; Jesper T Joergensen; Anders E Hansen; Andreas Kjaer
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

Review 5.  Molecular imaging of tumor hypoxia with positron emission tomography.

Authors:  Olivia J Kelada; David J Carlson
Journal:  Radiat Res       Date:  2014-03-27       Impact factor: 2.841

6.  2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.

Authors:  Christian M Becker; Nadine Rohwer; Tae Funakoshi; Thorsten Cramer; Wanja Bernhardt; Amy Birsner; Judah Folkman; Robert J D'Amato
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

Review 7.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

Review 8.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 9.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

10.  A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy.

Authors:  C P Lee; G S Payne; A Oregioni; R Ruddle; S Tan; F I Raynaud; D Eaton; M J Campbell; K Cross; G Halbert; M Tracy; J McNamara; B Seddon; M O Leach; P Workman; I Judson
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.